Share: Facebook Twitter LinkedIn
Activity Provided By:

Paradigm Medical Communications, LLC.

Influenza Now: Updates on New and Emerging Antivirals

Access Activity

Overview / Abstract:

Target Audience
This activity has been designed to address the educational needs of community and hospital pharmacists. It may also benefit other clinicians involved in the care of patients with influenza.

Statement of Need
Although antiviral agents can reduce the duration and severity of influenza symptoms and prevent complications (particularly in vulnerable patient populations), misconceptions about their indications and efficacy may lead to underuse, even in patients at high risk of influenza-related complications who would benefit most. This educational activity will dispel myths about influenza’s impact, testing, and treatment, including misperceptions about exciting new and emerging therapies.

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

• Apply effective strategies of patient and healthcare provider education on antiviral management of influenza.
• Evaluate the latest safety and efficacy data for new and emerging antiviral medications to determine how these may fit into the treatment paradigm

Expiration

Jan 31, 2020

Discipline(s)

Pharmacy CPE

Format

Webinar / Webcast / Video

Credits / Hours

1.5 hours

Accreditation

ACPE

Presenters / Authors / Faculty

Jason E. Bowling, MD
Associate Professor
Department of Medicine
Division of Infectious Diseases
UT Health San Antonio
San Antonio, TX

James S. Lewis II, PharmD, FIDSA
Infectious Diseases Pharmacy Supervisor
Co-Director, Antibiotic Stewardship
Departments of Pharmacy and Infectious Diseases
Oregon Health & Science University
Portland, OR

Activity Specialities / Related Topics

Public Health / Community Health, Primary Care, Pharmacology, Internal Medicine, Infectious Disease, Family Medicine, Emergency Medicine, Critical Care / Intensive Care, Acute Care

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Genentech, Inc.

Keywords / Search Terms

Paradigm Medical Communications, LLC. Influenza, antiviral, baloxavir, oseltamivir, zanamivir, peramivir, pharmacy, PCR, rapid influenza diagnostic test, rapid molecular assay, prophylaxis, neuraminidase inhibitor, polymerase complex inhibitor, adamantane, virus, pharmacology, primary care, internal medicine, family medicine,High-risk patients, influenza-related complications, CAPSTONE, viral shedding, resistance Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map